THE MECHANISM OF ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY CELL-BOUND C4B

被引:24
|
作者
FARRIES, TC
STEUER, KLK
ATKINSON, JP
机构
[1] WASHINGTON UNIV, SCH MED,DEPT MED,DIV RHEUMATOL,4566 SCOTT, BOX 8045, ST LOUIS, MO 63110 USA
[2] WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, MED LAB, ST LOUIS, MO 63110 USA
关键词
D O I
10.1016/0161-5890(90)90104-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Investigations into the mechanism of alternative pathway-dependent lysis of C4b-coated cells are reported. Test cells (EAC1q4b) were formed by reaction of sheep erythrocytes with antibody, C1 and C4. In C5-deficient serum, more C3b was deposited onto EAC1qC4b than onto control cells (EAC1q). The possibility that the C4bBb enzyme could form was considered, but no C3 convertase activity was generated when magnesium, properdin and factors B and D were added to EAC1qC4b. Binding studies employing radiolabeled components provided evidence that C4b bound the C3 convertase, C3bBbP, through a weak interaction with C3b. These data implied C3 conversion would be localized to the cell surface, thereby amplifying C3b deposition. This could be demonstrated in vitro. C3b, properdin, factor B and factor D were all required and the amplified C3b deposition was not due to deposition onto C4b itself. In serum, C5 convertase activity would be consequently expressed and cell lysis would result. This could be the mechanism by which the sera of C2-deficient patients mediate lysis of antibody coated sheep erythrocytes. © 1990.
引用
收藏
页码:1155 / 1161
页数:7
相关论文
共 50 条
  • [31] A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway
    Scesney, SM
    Makrides, SC
    Gosselin, ML
    Ford, PJ
    Andrews, BM
    Hayman, EG
    Marsh, HC
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (08) : 1729 - 1735
  • [32] Complement factor B and the alternative pathway of complement activation in bovine milk
    Rainard, P
    JOURNAL OF DAIRY RESEARCH, 2002, 69 (01) : 1 - 12
  • [33] DECREASED LEVELS OF SERUM COMPLEMENT C4B IN AUTISM
    WARREN, RP
    BURGER, RA
    TORRES, AR
    WARREN, WL
    ODELL, JD
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A227 - A227
  • [34] Cell-bound complement activation products are superior to serum complement C3 and C4 levels to detect complement activation in systemic lupus erythematosus: comment on the article by Aringer et al Reply
    Aringer, Martin
    Costenbader, Karen H.
    Doerner, Thomas
    Johnson, Sindhu R.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (05) : 860 - 861
  • [35] COVALENT ASSOCIATION OF C3B WITH C4B WITHIN C5 CONVERTASE OF THE CLASSICAL COMPLEMENT PATHWAY
    TAKATA, Y
    KINOSHITA, T
    KOZONO, H
    TAKEDA, J
    TANAKA, E
    HONG, K
    INOUE, K
    JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06): : 1494 - 1507
  • [36] Cell-bound complement activation products (CB-CAPs) as a source of lupus biomarkers
    Calano, Sarah J.
    Shih, Pei-an B.
    Liu, Chau-Ching
    Kao, Amy H.
    Navratil, Jeannine S.
    Manzi, Susan
    Ahearn, Joseph M.
    CURRENT TOPICS IN COMPLEMENT, 2006, 586 : 381 - 390
  • [37] Distinct Cell-bound Complement Activation Signatures Are Observed in Patients with Systemic Lupus Erythematosus
    Schriefer, Rebecca
    Arguelles, Gabriel
    Atkinson, John
    Hourcade, Dennis
    Kim, Alfred
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [38] CLONAL VARIATIONS IN COMPLEMENT ACTIVATION AND DEPOSITION OF C3B AND C4B ON MODEL IMMUNE-COMPLEXES
    YOKOYAMA, I
    WAXMAN, F
    IMMUNOLOGY, 1993, 80 (02) : 168 - 176
  • [39] DISTRIBUTION OF COMPLEMENT RECEPTORS SPECIFIC FOR C4B AND C3D IN B-CELL LYMPHOMAS
    COSSMAN, J
    JAFFE, ES
    LABORATORY INVESTIGATION, 1979, 40 (02) : 249 - 249
  • [40] CELL DAMAGE BY LEUKOCYTES INDUCED BY TARGET CELL-BOUND COMPLEMENT
    MULLEREBERHARD, HJ
    PERLMANN, P
    PERLMANN, H
    MANNI, JA
    JOURNAL OF IMMUNOLOGY, 1968, 101 (04): : 820 - +